Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments

Neoplasia - Tập 21 - Trang 239-246 - 2019
Santosh Kumar Bharti1, Samata Kakkad1, Pierre Danhier1, Flonne Wildes1, Marie-France Penet1,2, Balaji Krishnamachary1, Zaver M. Bhujwalla1,2,3
1Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
2Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore, MD, USA
3Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Tài liệu tham khảo

Gilkes, 2013, Role of hypoxia-inducible factors in breast cancer metastasis, Future Oncol, 9, 1623, 10.2217/fon.13.92 Penet, 2011, MRI of metastasis-permissive microenvironments, Future Oncol, 7, 1269, 10.2217/fon.11.114 Semenza, 2010, Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics, Oncogene, 29, 625, 10.1038/onc.2009.441 Gilkes, 2014, Hypoxia and the extracellular matrix: drivers of tumour metastasis, Nat Rev Cancer, 14, 430, 10.1038/nrc3726 Fraga, 2015, Hypoxia and prostate cancer aggressiveness: a tale with many endings, Clin Genitourin Cancer, 13, 295, 10.1016/j.clgc.2015.03.006 Hompland, 2018, Combined MR imaging of oxygen consumption and supply reveals tumor hypoxia and aggressiveness in prostate cancer patients, Cancer Res, 78, 4774, 10.1158/0008-5472.CAN-17-3806 Stewart, 2008, Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score, Oncol Rep, 20, 1561 Ambrosio, 2016, Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer, Diagn Pathol, 11, 45, 10.1186/s13000-016-0495-1 Fernandez, 2015, Dual targeting of the androgen receptor and hypoxia-inducible factor 1alpha pathways synergistically inhibits castration-resistant prostate cancer cells, Mol Pharmacol, 87, 1006, 10.1124/mol.114.097477 Milosevic, 2012, Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer, Clin Cancer Res, 18, 2108, 10.1158/1078-0432.CCR-11-2711 Vergis, 2008, Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study, Lancet Oncol, 9, 342, 10.1016/S1470-2045(08)70076-7 Dunning, 1963, Prostate cancer in the rat, Natl Cancer Inst Monogr, 12, 351 Isaacs, 1986, Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers, Prostate, 9, 261, 10.1002/pros.2990090306 White, 2016, Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response, Cancer Lett, 380, 69, 10.1016/j.canlet.2016.06.003 Zhao, 2003, Tumor oxygen dynamics: correlation of in vivo MRI with histological findings, Neoplasia, 5, 308, 10.1016/S1476-5586(03)80024-6 Glowa, 2016, Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors, Cancer Lett, 378, 97, 10.1016/j.canlet.2016.05.013 Horsman, 2012, Imaging hypoxia to improve radiotherapy outcome, Nat Rev Clin Oncol, 9, 674, 10.1038/nrclinonc.2012.171 Unwith, 2015, The potential role of HIF on tumour progression and dissemination, Int J Cancer, 136, 2491, 10.1002/ijc.28889 Vaupel, 1998, Modulation of tumor oxygenation, Int J Radiat Oncol Biol Phys, 42, 843, 10.1016/S0360-3016(98)00324-1 Danhier, 2012, Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizing effect of paclitaxel, PLoS One, 7, 10.1371/journal.pone.0040772 Toma-Dasu, 2013, Modelling tumour oxygenation, reoxygenation and implications on treatment outcome, Comput Math Methods Med, 2013, 141087, 10.1155/2013/141087 Hu, 2007, The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha, Mol Biol Cell, 18, 4528, 10.1091/mbc.e06-05-0419 Tian, 1997, Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells, Genes Dev, 11, 72, 10.1101/gad.11.1.72 Berchner-Pfannschmidt, 2008, Imaging of the hypoxia-inducible factor pathway: insights into oxygen sensing, Eur Respir J, 32, 210, 10.1183/09031936.00013408 Danhier, 2015, Combining optical reporter proteins with different half-lives to detect temporal evolution of hypoxia and reoxygenation in tumors, Neoplasia, 17, 871, 10.1016/j.neo.2015.11.007 Penet, 2017, Structure and function of a prostate cancer dissemination-permissive extracellular matrix, Clin Cancer Res, 23, 2245, 10.1158/1078-0432.CCR-16-1516 Penet, 2009, Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft, Cancer Res, 69, 8822, 10.1158/0008-5472.CAN-09-1782 Louie, 2010, Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation, Breast Cancer Res, 12, R94, 10.1186/bcr2773 Bizzarro, 2017, Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness, Cell Adh Migr, 11, 247, 10.1080/19336918.2016.1259056 Chen, 2016, Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity, Exp Cell Res, 349, 302, 10.1016/j.yexcr.2016.10.023 Bhujwalla, 2001, Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts, Neoplasia, 3, 143, 10.1038/sj.neo.7900129 Fitzpatrick, 1998, Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen, Exp Cell Res, 245, 155, 10.1006/excr.1998.4240